标题
Understanding pharmacokinetics to improve tuberculosis treatment outcome
作者
关键词
-
出版物
Expert Opinion on Drug Metabolism & Toxicology
Volume 10, Issue 6, Pages 813-823
出版商
Informa Healthcare
发表日期
2014-03-06
DOI
10.1517/17425255.2014.895813
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Effects of rifampin-based antituberculosis therapy on plasma efavirenz concentrations in children vary by CYP2B6 genotype
- (2013) Helen M. McIlleron et al. AIDS
- Plasma Drug Activity in Patients on Treatment for Multidrug-Resistant Tuberculosis
- (2013) Stellah G. Mpagama et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Sensititre MYCOTB MIC Plate for Testing Mycobacterium tuberculosis Susceptibility to First- and Second-Line Drugs
- (2013) Jongseok Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania
- (2013) Stellah G Mpagama et al. BMC INFECTIOUS DISEASES
- A multi-arm multi-stage clinical trial design for binary outcomes with application to tuberculosis
- (2013) Daniel J Bratton et al. BMC Medical Research Methodology
- Costs of tuberculosis disease in the European Union: a systematic analysis and cost calculation
- (2013) R. Diel et al. EUROPEAN RESPIRATORY JOURNAL
- Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment?
- (2013) Shashikant Srivastava et al. EUROPEAN RESPIRATORY JOURNAL
- Drug concentration in lung tissue in multidrug-resistant tuberculosis
- (2013) Onno W. Akkerman et al. EUROPEAN RESPIRATORY JOURNAL
- Age, nutritional status and INH acetylator status affect pharmacokinetics of anti-tuberculosis drugs in children
- (2013) G. Ramachandran et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes
- (2013) J. G. Pasipanodya et al. JOURNAL OF INFECTIOUS DISEASES
- Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance data
- (2013) Dennis Falzon et al. LANCET INFECTIOUS DISEASES
- Tuberculosis biomarkers discovery: developments, needs, and challenges
- (2013) Robert S Wallis et al. LANCET INFECTIOUS DISEASES
- Indolcarboxamide Is a Preclinical Candidate for Treating Multidrug-Resistant Tuberculosis
- (2013) S. P. S. Rao et al. Science Translational Medicine
- Population Pharmacokinetics and Pharmacodynamics of Ofloxacin in South African Patients with Multidrug-Resistant Tuberculosis
- (2012) Emmanuel Chigutsa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Linezolid in Patients with Multidrug-Resistant Tuberculosis
- (2012) D. H. Vu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Retooling Existing Tuberculosis Drugs for Children
- (2012) J. A. Seddon et al. CLINICAL INFECTIOUS DISEASES
- The future of molecular diagnostics for drug-resistant tuberculosis
- (2012) Scott K Heysell et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Evaluation of the Sensititre MycoTB Plate for Susceptibility Testing of the Mycobacterium tuberculosis Complex against First- and Second-Line Agents
- (2012) L. Hall et al. JOURNAL OF CLINICAL MICROBIOLOGY
- PanACEA: a new approach to tuberculosis research
- (2012) Talha Burki LANCET INFECTIOUS DISEASES
- Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial
- (2012) Rovina Ruslami et al. LANCET INFECTIOUS DISEASES
- Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis
- (2012) Myungsun Lee et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plasma Drug Activity Assay for Treatment Optimization in Tuberculosis Patients
- (2011) Scott K. Heysell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Protease inhibitor-containing antiretroviral treatment and tuberculosis: can rifabutin fill the breach? [Review article]
- (2011) A. Loeliger et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Multidrug-Resistant Tuberculosis Not Due to Noncompliance but to Between-Patient Pharmacokinetic Variability
- (2011) Shashikant Srivastava et al. JOURNAL OF INFECTIOUS DISEASES
- Integration of Antiretroviral Therapy with Tuberculosis Treatment
- (2011) Salim S. Abdool Karim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Earlier versus Later Start of Antiretroviral Therapy in HIV-Infected Adults with Tuberculosis
- (2011) François-Xavier Blanc et al. NEW ENGLAND JOURNAL OF MEDICINE
- Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis
- (2011) Diane V. Havlir et al. NEW ENGLAND JOURNAL OF MEDICINE
- Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis
- (2010) Armand Van Deun et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- An Oracle: Antituberculosis Pharmacokinetics-Pharmacodynamics, Clinical Correlation, and Clinical Trial Simulations To Predict the Future
- (2010) Jotam Pasipanodya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment Outcomes among Patients with Extensively Drug‐Resistant Tuberculosis: Systematic Review and Meta‐Analysis
- (2010) Karen R. Jacobson et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetics and Whole‐Blood Bactericidal Activity againstMycobacterium tuberculosisof Single Doses of PNU‐100480 in Healthy Volunteers
- (2010) Robert S. Wallis et al. JOURNAL OF INFECTIOUS DISEASES
- Efflux‐Pump–Derived Multiple Drug Resistance to Ethambutol Monotherapy inMycobacterium tuberculosisand the Pharmacokinetics and Pharmacodynamics of Ethambutol
- (2010) Shashikant Srivastava et al. JOURNAL OF INFECTIOUS DISEASES
- Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy
- (2010) Salim S. Abdool Karim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cerebrospinal fluid concentrations of antituberculosis agents in adults and children
- (2010) P.R. Donald TUBERCULOSIS
- Update on Rifampin and Rifabutin Drug Interactions
- (2009) Anne M. Baciewicz et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Pharmacokinetics-Pharmacodynamics of Pyrazinamide in a Novel In Vitro Model of Tuberculosis for Sterilizing Effect: a Paradigm for Faster Assessment of New Antituberculosis Drugs
- (2009) T. Gumbo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rifampin pharmacokinetics in children, with and without human immunodeficiency virus infection, hospitalized for the management of severe forms of tuberculosis
- (2009) Hendrik Simon Schaaf et al. BMC Medicine
- A Randomized Trial Comparing Plasma Drug Concentrations and Efficacies between 2 Nonnucleoside Reverse‐Transcriptase Inhibitor–Based Regimens in HIV‐Infected Patients Receiving Rifampicin: The N2R Study
- (2009) Weerawat Manosuthi et al. CLINICAL INFECTIOUS DISEASES
- Isoniazid Plasma Concentrations in a Cohort of South African Children with Tuberculosis: Implications for International Pediatric Dosing Guidelines
- (2009) Helen McIlleron et al. CLINICAL INFECTIOUS DISEASES
- Isoniazid, Rifampin, Ethambutol, and Pyrazinamide Pharmacokinetics and Treatment Outcomes among a Predominantly HIV‐Infected Cohort of Adults with Tuberculosis from Botswana
- (2009) Sekai Chideya et al. CLINICAL INFECTIOUS DISEASES
- Association of high T allele frequency of CYP2B6 G516T polymorphism among ethnic south Indian HIV-infected patients with elevated plasma efavirenz and nevirapine
- (2009) G. Ramachandran et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Tuberculosis and diabetes mellitus: convergence of two epidemics
- (2009) Kelly E Dooley et al. LANCET INFECTIOUS DISEASES
- Treatment of Active Pulmonary Tuberculosis in Adults: Current Standards and Recent Advances
- (2009) Ronald G Hall et al. PHARMACOTHERAPY
- Dried Blood Spot Methods in Therapeutic Drug Monitoring: Methods, Assays, and Pitfalls
- (2009) Peter M Edelbroek et al. THERAPEUTIC DRUG MONITORING
- Early and Extended Early Bactericidal Activity of Linezolid in Pulmonary Tuberculosis
- (2008) Reynaldo Dietze et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Early Bactericidal Activity and Pharmacokinetics of the Diarylquinoline TMC207 in Treatment of Pulmonary Tuberculosis
- (2008) R. Rustomjee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multidrug-resistant and extensively drug-resistant tuberculosis: consequences for the global HIV community
- (2008) Sheela Shenoi et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Peak plasma rifampicin level in tuberculosis patients with slow culture conversion
- (2008) K.-C. Chang et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Outcomes of Nevirapine- and Efavirenz-Based Antiretroviral Therapy When Coadministered With Rifampicin-Based Antitubercular Therapy
- (2008) Andrew Boulle JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Diabetes Mellitus Increases the Risk of Active Tuberculosis: A Systematic Review of 13 Observational Studies
- (2008) Christie Y Jeon et al. PLOS MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now